Pharmaceutical commercial leaders and marketers face many challenges to create differentiation in crowded markets for their mature portfolio and emerging pipeline candidates. Implementing a digital therapeutics (DTx), remote patient monitoring and companion apps strategy can help a portfolio drive market adoption, physician preference and patient adherence.
Panelists will discuss emerging trends in the healthcare industry that will drive DTx adoption, the benefits of building a DTx strategy, and a case study demonstrating important lessons learned from deploying DTx and remote patient monitoring solutions in the pharmaceutical landscape.
Register for this webinar to learn about the critical building blocks to help build a DTx and remote patient monitoring strategy.
Marcus Grindstaff, Senior Vice President of Connected Health, PRA Health Sciences
Marcus Grindstaff is a business strategy and product technology leader with more than 20 years of experience in the high tech industry. Marcus is currently the Senior Vice President – Connected Health, and has responsibility for product development. Prior to this role, Marcus held several roles at Care Innovations including Chief Operating Officer, Vice President, Sales and Market Development.
Marcus joined Care Innovations at its formation in 2011, from the Intel Digital Health Group. A 17-year Intel veteran, Marcus held a variety of positions including leadership roles in both Intel Capital and Intel’s core semiconductor business. Marcus also served as the Technology Director in Intel’s Ultra-mobility Office of Big Ideas, where he was responsible for building the Low Power Chipset team, delivering Intel’s first low power chipset for the Atom* microprocessor.
Throughout his career, Marcus has focused on growing exceptional teams chartered with delivering strategy, technology, marketing and product execution throughout the U.S., Asia and Europe. He is also a passionate spokesperson for reforming the healthcare delivery system, and serves on the board of the National Alliance for Caregiving. Marcus earned a Bachelor of Computer Engineering degree from the University of California, Davis.
Brian Greene, Vice President of Connected and Digital Health, PRA Health Sciences
Brian Greene joined Care Innovations in 2012 and transitioned to PRA Health Sciences via acquisition in January of 2020 where he currently serves as Vice President of Sales in PRA’s Connected Health group. Brian is responsible for developing go-to-market strategies, driving business development and revenue objectives within PRA’s Connected Health Group. He is also responsible for building and managing the business development team and coordinating with the marketing and clinical teams to support PRA’s digital platform solutions.
Brian has held multiple leadership positions within Fortune 100 companies in the pharmaceutical, wellness and connected health industries. He has a proven track record of business development and building high preforming health care business development teams. Brian brings a wealth of experience partnering with payers, hospital systems, physician groups and Pharma. Brian attended Western Michigan University where he received a Bachelor of Science.
Who Should Attend?
- US and EU Pharmaceutical and biotechs
- Brand/Marketing Managers
- Payer Marketing & Market Access
- Product management
- IT Personnel
- Clinical Development
What You Will Learn
In this webinar participants will learn about:
- Emerging trends in healthcare that will drive DTx adoption by providers and payers
- The benefits of building a DTx strategy to a drug portfolio
- A Case Study: Lessons learned in deploying DTx and remote patient monitoring solutions in the pharmaceutical landscape
- The critical building blocks to help build a DTx and remote patient monitoring strategy
PRA Health Sciences
PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people are passionate about clinical research, working tirelessly to provide quality results. We offer exceptional experience across all phases and therapeutic areas and a broad spectrum of solutions, ranging from full-service clinical development to a pioneering embedded model.
With 16,000+ employees covering 90+ countries, we bolster an impressive global presence with keen local insights. Our project teams harness their understanding of local regulations, standards of care and cultural customs to effectively align our approaches with each study’s unique goals.
At PRA, we love what do because we are making a difference in the lives of patients and their family members worldwide. Over the years, we have contributed to the development of numerous drugs now available to countless patients. From our scientific and medical experts to therapeutically aligned project managers and monitors, we provide the commitment and expertise needed for today’s complex studies.